Abstract
Until such time as new products under development provide us with the ideal drug, current research on the treatment of obesity concentrates on diet and way of life. The value of leguminous plants and a reasonable amount of fruit is emphasized, and prescription is assisted by computer programs. Physical exercise, particularly when moderate and prolonged, uses lipolysis for the best. Pharmaceutical research is directed towards drugs acting on the hypothalamus, devoid of amphetamine-like effects (e.g. d-fenfluramine, PM 170, mazindol or even naloxone and bombesin), acting on insulin secretion (e.g. phenytoin) or directly stimulating lipolysis in fatty tissue (e.g. RO 220654).
Collapse